Home Carboxes 40180-04-9
40180-04-9,MFCD00867339
Catalog No.:AA00C0U9

40180-04-9 | 2-{2,3-dichloro-4-[(thiophen-2-yl)carbonyl]phenoxy}acetic acid

Pack Size
Purity
Availability
Price(USD)
Quantity
  
250mg
97%
in stock  
$53.00   $37.00
- +
5g
98%
in stock  
$809.00   $567.00
- +
10g
98%
in stock  
$1,407.00   $985.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA00C0U9
Chemical Name:
2-{2,3-dichloro-4-[(thiophen-2-yl)carbonyl]phenoxy}acetic acid
CAS Number:
40180-04-9
Molecular Formula:
C13H8Cl2O4S
Molecular Weight:
331.1712
MDL Number:
MFCD00867339
SMILES:
OC(=O)COc1ccc(c(c1Cl)Cl)C(=O)c1cccs1
Properties
Properties
 
BP:
534.6°C at 760 mmHg  
Form:
Solid  
MP:
148-149oC  
Solubility:
DMSO: soluble5mg/mL (clear solution)  
Storage:
Keep in dry area;-20 ℃;  

Computed Properties
 
Complexity:
379  
Covalently-Bonded Unit Count:
1  
Heavy Atom Count:
20  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
1  
Rotatable Bond Count:
5  
XLogP3:
4.1  

Downstream Synthesis Route
40180-04-9    115-77-5   
3-hydroxy-2,2-bis(hydroxymethyl)propyl2-(2,3-dichloro-4-(thiophene-2-carbonyl)phenoxy)acetate 

[1]CurrentPatentAssignee:AERIEPHARMACEUTICALSINC-US2007/254920,2007,A1Locationinpatent:Page/Pagecolumn33

40180-04-9   
2,3-Dichloro-4-(2-thenoyl)phenoxyacetylchloride 

[1]CurrentPatentAssignee:DUKEUNIVERSITY-US2006/135609,2006,A1Locationinpatent:Page/Pagecolumn6-7

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-US3989838,1976,A

3-2,3-dichloro-4-(2-thenoyl)-phenoxy-propanediol 
  40180-04-9 

[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-US4166061,1979,A

Literature

Title: Cell-based assay using glutathione-depleted HepaRG and HepG2 human liver cells for predicting drug-induced liver injury.

Journal: Toxicology in vitro : an international journal published in association with BIBRA 20180401

Title: Customised in vitro model to detect human metabolism-dependent idiosyncratic drug-induced liver injury.

Journal: Archives of toxicology 20180101

Title: Evaluating the Role of Multidrug Resistance Protein 3 (MDR3) Inhibition in Predicting Drug-Induced Liver Injury Using 125 Pharmaceuticals.

Journal: Chemical research in toxicology 20170515

Title: High content analysis assay for prediction of human hepatotoxicity in HepaRG and HepG2 cells.

Journal: Toxicology in vitro : an international journal published in association with BIBRA 20160601

Title: Direct and metabolism-dependent cytochrome P450 inhibition assays for evaluating drug-drug interactions.

Journal: Journal of applied toxicology : JAT 20130201

Title: Identification of CYP isozymes involved in benzbromarone metabolism in human liver microsomes.

Journal: Biopharmaceutics & drug disposition 20121101

Title: Identification of protein targets of reactive metabolites of tienilic acid in human hepatocytes.

Journal: Chemical research in toxicology 20120521

Title: Differential oxidation of two thiophene-containing regioisomers to reactive metabolites by cytochrome P450 2C9.

Journal: Chemical research in toxicology 20120416

Title: Development of an in vitro system with human liver microsomes for phenotyping of CYP2C9 genetic polymorphisms with a mechanism-based inactivator.

Journal: Drug metabolism and disposition: the biological fate of chemicals 20120401

Title: Idiosyncratic reactions and metabolism of sulfur-containing drugs.

Journal: Expert opinion on drug metabolism & toxicology 20120401

Title: Antihypertensive drugs and risk of incident gout among patients with hypertension: population based case-control study.

Journal: BMJ (Clinical research ed.) 20120101

Title: Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

Journal: PLoS computational biology 20111201

Title: Combination of GSH trapping and time-dependent inhibition assays as a predictive method of drugs generating highly reactive metabolites.

Journal: Drug metabolism and disposition: the biological fate of chemicals 20110701

Title: CYP2C9-mediated metabolic activation of losartan detected by a highly sensitive cell-based screening assay.

Journal: Drug metabolism and disposition: the biological fate of chemicals 20110501

Title: A predictive ligand-based Bayesian model for human drug-induced liver injury.

Journal: Drug metabolism and disposition: the biological fate of chemicals 20101201

Title: Novel metabolic bioactivation mechanism for a series of anti-inflammatory agents (2,5-diaminothiophene derivatives) mediated by cytochrome p450 enzymes.

Journal: Drug metabolism and disposition: the biological fate of chemicals 20100901

Title: Characterization of glutathione conjugates of duloxetine by mass spectrometry and evaluation of in silico approaches to rationalize the site of conjugation for thiophene containing drugs.

Journal: Chemical research in toxicology 20100816

Title: Identification and characterisation of new inhibitors for the human hematopoietic prostaglandin D2 synthase.

Journal: European journal of medicinal chemistry 20100201

Title: Chem2Bio2RDF: a semantic framework for linking and data mining chemogenomic and systems chemical biology data.

Journal: BMC bioinformatics 20100101

Title: Evaluation of the potential for drug-induced liver injury based on in vitro covalent binding to human liver proteins.

Journal: Drug metabolism and disposition: the biological fate of chemicals 20091201

Title: New insights into the structural features and functional relevance of human cytochrome P450 2C9. Part I.

Journal: Current drug metabolism 20091201

Title: Aqua-(2,2'-bipyridine-κN,N')bis-(thio-phene-2-carboxyl-ato-κO)copper(II).

Journal: Acta crystallographica. Section E, Structure reports online 20090801

Title: Cocktail-substrate assay system for mechanism-based inhibition of CYP2C9, CYP2D6, and CYP3A using human liver microsomes at an early stage of drug development.

Journal: Xenobiotica; the fate of foreign compounds in biological systems 20090601

Title: Mechanism-based inactivation of cytochrome P450 2C9 by tienilic acid and (+/-)-suprofen: a comparison of kinetics and probe substrate selection.

Journal: Drug metabolism and disposition: the biological fate of chemicals 20090101

Title: Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development.

Journal: Current medicinal chemistry 20090101

Title: Prediction of pharmacological and xenobiotic responses to drugs based on time course gene expression profiles.

Journal: PloS one 20090101

Title: Involvement of cytochrome P450-mediated metabolism in tienilic acid hepatotoxicity in rats.

Journal: Toxicology letters 20081215

Title: The crucial protective role of glutathione against tienilic acid hepatotoxicity in rats.

Journal: Toxicology and applied pharmacology 20081015

Title: Can in vitro metabolism-dependent covalent binding data in liver microsomes distinguish hepatotoxic from nonhepatotoxic drugs? An analysis of 18 drugs with consideration of intrinsic clearance and daily dose.

Journal: Chemical research in toxicology 20080901

Title: Markers of electrophilic stress caused by chemically reactive metabolites in human hepatocytes.

Journal: Drug metabolism and disposition: the biological fate of chemicals 20080501

Title: A generic method to detect electrophilic intermediates using isotopic pattern triggered data-dependent high-resolution accurate mass spectrometry.

Journal: Rapid communications in mass spectrometry : RCM 20080401

Title: A novel approach to cyclin-dependent kinase 5/p25 inhibitors: A potential treatment for Alzheimer's disease.

Journal: Bioorganic & medicinal chemistry 20071001

Title: Changes in gene expression induced by tienilic Acid and sulfamethoxazole: testing the danger hypothesis.

Journal: Journal of immunotoxicology 20071001

Title: Toxicological significance of mechanism-based inactivation of cytochrome p450 enzymes by drugs.

Journal: Critical reviews in toxicology 20070601

Title: Prediction of in vivo potential for metabolic activation of drugs into chemically reactive intermediate: correlation of in vitro and in vivo generation of reactive intermediates and in vitro glutathione conjugate formation in rats and humans.

Journal: Chemical research in toxicology 20070301

Title: Ethanol oxidation into acetaldehyde by 16 recombinant human cytochrome P450 isoforms: role of CYP2C isoforms in human liver microsomes.

Journal: Toxicology letters 20061215

Title: Evaluation of time-dependent cytochrome P450 inhibition using cultured human hepatocytes.

Journal: Drug metabolism and disposition: the biological fate of chemicals 20060801

Title: Tienilic acid enhances hyperbilirubinemia in Eisai hyperbilirubinuria rats through hepatic multidrug resistance-associated protein 3 and heme oxygenase-1 induction.

Journal: Toxicological sciences : an official journal of the Society of Toxicology 20060601

Title: Kinetics of tienilic acid bioactivation and functional generation of drug-protein adducts in intact rat hepatocytes.

Journal: Biochemical pharmacology 20051205

Title: Effects of novel ethacrynic acid derivatives on human trabecular meshwork cell shape, actin cytoskeletal organization, and transcellular fluid flow.

Journal: Biological & pharmaceutical bulletin 20051201

Title: Automated assessment of time-dependent inhibition of human cytochrome P450 enzymes using liquid chromatography-tandem mass spectrometry analysis.

Journal: Drug metabolism and disposition: the biological fate of chemicals 20051101

Title: Cytochrome p450 enzymes mechanism based inhibitors: common sub-structures and reactivity.

Journal: Current drug metabolism 20051001

Title: Automated screening with confirmation of mechanism-based inactivation of CYP3A4, CYP2C9, CYP2C19, CYP2D6, and CYP1A2 in pooled human liver microsomes.

Journal: Drug metabolism and disposition: the biological fate of chemicals 20050801

Title: Screening procedure for detection of diuretics and uricosurics and/or their metabolites in human urine using gas chromatography-mass spectrometry after extractive methylation.

Journal: Therapeutic drug monitoring 20050801

Title: Cytochrome P450 and liver diseases.

Journal: Current drug metabolism 20040601

Title: Essential requirements for substrate binding affinity and selectivity toward human CYP2 family enzymes.

Journal: Archives of biochemistry and biophysics 20030101

Title: Substrate selectivity of human cytochrome P450 2C9: importance of residues 476, 365, and 114 in recognition of diclofenac and sulfaphenazole and in mechanism-based inactivation by tienilic acid.

Journal: Archives of biochemistry and biophysics 20030101

Title: Immune-mediated drug-induced liver disease.

Journal: Clinics in liver disease 20020801

Title: Ticlopidine as a selective mechanism-based inhibitor of human cytochrome P450 2C19.

Journal: Biochemistry 20011009

Title: Use of isotopes and LC-MS-ESI-TOF for mechanistic studies of tienilic acid metabolic activation.

Journal: Advances in experimental medicine and biology 20010101

Title: Human cytochrome P450 2E1 is a major autoantigen associated with halothane hepatitis.

Journal: Chemical research in toxicology 19960101

Title: Drug-induced hepatitis associated with anticytoplasmic organelle autoantibodies.

Journal: Hepatology (Baltimore, Md.) 19850101

Title: Vocal cord hematomas complicating anticoagulant therapy.

Journal: Annals of emergency medicine 19840701

Title: A new anti-liver-kidney microsome antibody (anti-LKM2) in tienilic acid-induced hepatitis.

Journal: Clinical and experimental immunology 19840301

Title: Acute effects of alkylating agents on canine renal function and ultrastructure: high-dose ethacrynic acid vs. dihydroethacrynic acid and ticrynafen.

Journal: The Journal of pharmacology and experimental therapeutics 19840301

Title: Hepatotoxicity associated with ticrynafen--a uricosuric diuretic.

Journal: The American journal of gastroenterology 19820601

Title: Effects of prostaglandins inhibition on changes in active and inactive renin induced by antihypertensive drugs.

Journal: Clinical and experimental hypertension. Part A, Theory and practice 19820101

Title: Adverse reactions associated with ticrynafen use.

Journal: JAMA 19800201

Title: Tienilic acid in the treatment of mild to moderate hypertension.

Journal: Clinical and experimental pharmacology & physiology 19800101

Title: Comparison of natriuretic, uricosuric, and antihypertensive properties of tienilic acid, bendrofluazide, and spironolactone.

Journal: British medical journal 19790127

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Tags:40180-04-9 Molecular Formula|40180-04-9 MDL|40180-04-9 SMILES|40180-04-9 2-{2,3-dichloro-4-[(thiophen-2-yl)carbonyl]phenoxy}acetic acid